ДОЛГ Изменить Дата
AbbVie USD 70.82B 2.04B 2026-06
Agenus USD 35.54M 2.34M 2025-03
Amgen USD 57.3B 19M 2026-06
AstraZeneca USD 32.24B 1.68B 2026-06
Bristol-Myers Squibb USD 42.88B 2.18B 2026-09
Celldex Therapeutics USD 4.9M 3M 2026-06
CSL USD 11.96B 219M 2024-12
Eli Lilly USD 54.91B 11.54B 2026-06
Gilead Sciences USD 26.25B 4.07B 2026-06
GlaxoSmithKline GBP 18.24B 818M 2026-06
Glaxosmithkline GBP 23.7B 4.65B 2026-09
Incyte USD 38.27M 1.16M 2026-06
Intrexon USD 0 13.82M 2024-06
J&J USD 49.04B 5.95B 2026-06
Jiangsu Hengrui CNY 421.65M 353.67M 2026-09
Karyopharm Therapeutics USD 299.23M 35.14M 2025-12
MacroGenics USD 35.09M 1.42M 2026-06
Merck EUR 12.3B 264M 2026-06
Merck USD 53.91B 4.79B 2026-06
Northwest Biotherapeutics USD 32.94M 6.93M 2023-09
Novartis USD 49.01B 2.02B 2026-06
Novavax USD 233.31M 4.23M 2024-09
Pfizer USD 62.67B 523M 2026-09
Regeneron Pharmaceuticals USD 2.71B 400K 2026-06
Rigel Pharmaceuticals USD 59.69M 90K 2024-06
Sangamo BioSciences USD 0 0 2022-06
Veracyte USD 40.11M 774K 2026-06